Suppr超能文献

接受家庭肠外营养患者的抗菌锁。

Antimicrobial Locks in Patients Receiving Home Parenteral Nutrition.

机构信息

Department of Medicine, Division of Gastroenterology, Centre Hospitalier de l'Universite de Montreal (CHUM), Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM), 1051 Rue Sanguinet, Montreal, Québec H2X 3E4, Canada.

Intestinal Failure Unit, Department of Gastroenterology and Hepatology, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.

出版信息

Nutrients. 2020 Feb 10;12(2):439. doi: 10.3390/nu12020439.

Abstract

Catheter-related bloodstream infection (CRBSI) is one of the most common and potentially fatal complications in patients receiving home parenteral nutrition (HPN). In order to prevent permanent venous access loss, catheter locking with an antimicrobial solution has received significant interest and is often a favored approach as part of the treatment of CRBSI, but mainly for its prevention. Several agents have been used for treating and preventing CRBSI, for instance antibiotics, antiseptics (ethanol, taurolidine) and, historically, anticoagulants such as heparin. Nonetheless, current guidelines do not provide clear guidance on the use of catheter locks. Therefore, this review aims to provide a better understanding of the current use of antimicrobial locking in patients on HPN as well as reviewing the available data on novel compounds. Despite the fact that our current knowledge on catheter locking is still hampered by several gaps, taurolidine and ethanol solutions seem promising for prevention and potentially, but not proven, treatment of CRBSI. Additional studies are warranted to further characterize the efficacy and safety of these agents.

摘要

导管相关性血流感染(CRBSI)是接受家庭肠外营养(HPN)治疗的患者中最常见且潜在致命的并发症之一。为了防止永久性静脉通路丧失,用抗菌溶液对导管进行锁定已引起广泛关注,并且通常作为治疗 CRBSI 的一种首选方法,主要是为了预防 CRBSI。已经有几种药物被用于治疗和预防 CRBSI,例如抗生素、防腐剂(乙醇、牛磺罗定),以及历史上的抗凝剂如肝素。然而,目前的指南并没有就导管锁定的使用提供明确的指导。因此,本综述旨在更好地了解目前在接受 HPN 治疗的患者中使用抗菌锁定的情况,并回顾关于新型化合物的现有数据。尽管我们目前对导管锁定的认识仍然受到一些空白的限制,但牛磺罗定和乙醇溶液似乎在预防和潜在治疗 CRBSI 方面有一定的前景,但尚未得到证实。需要进一步的研究来进一步确定这些药物的疗效和安全性。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验